Growing clinical pipeline in multiple indications and strong collaborations.
A high-throughput platform for antigen and TCR discovery.
Listed on the Frankfurt Stock Exchange (Deutsche Börse) with a market cap of EUR330 million.
Fundraising to expand the company's ongoing clinical program with its T-cell receptor-modified T cells (TCR-T) and to progress its pipeline of potential TCR-T candidates for future clinical development.
About Medigene
Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard, TecDAX) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative immunotherapies to target various forms and stages of cancer. Medigene concentrates on the development of personalized T cell-based therapies, with associated projects currently in pre-clinical and clinical development.
Should you want to know more about this transaction, you can contact one of the team members above
Bryan, Garnier & Co acts as Lead Manager on Medigene’s EUR48.3 million offering
Bryan, Garnier & Co acted as Lead Manager alongside Guggenheim Securities and Baader Bank.
EUR32.3 million raised in an oversubscribed Accelerated Bookbuild targeting institutional investors in Europe and in the US.
Offering priced at EUR 14.5 per share representing a discount of 2.3% to the last market closing price.
Strong demand enabled QVT Financial LP, a major shareholder of Medigene, to sell c. 1.1 million shares in a secondary offering as part of a general restructuring across its funds.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
